Showing results (181-190 of 439) with videos related to
Sort By:
Pageof 44
Seminars in Urologic Oncology|August 26, 1999
The role of dietary manipulation in biochemical recurrence of prostate cancer after radical prostatectomyC T Lee, W R FairAnnals of Internal Medicine|August 1, 1996
Prostate cancer: emerging concepts. Part IIM B Garnick, W R FairAnnals of Internal Medicine|July 15, 1996
Prostate cancer: emerging concepts. Part IM B Garnick, W R FairInvestigative Urology|September 1, 1976
Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinomaR U Anderson, W R FairBritish Journal of Urology|April 1, 1976
Influence of vesico-ureteral reflux on the response to treatment of urinary tract infections in female childrenW R Fair, D E GovanAnnals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2006
Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatmentF C Maluf, C Cordon-Cardo, D A Verbel, et al.Clinical Chemistry|October 6, 2000
Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samplesF P Wikman, M L Lu, T Thykjaer, et al.Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sitesC Cordon-Cardo, J P O'Brien, D Casals, et al.Molecular Urology|November 4, 2000
Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancerW R Fair, J E BetancourtSurgical Oncology Clinics of North America|October 6, 1997
Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experienceW R Fair, H I ScherPageof 44